The outcome for children with acute myeloid leukemia (AML) has improved significantly over
the past 30 years, with complete remission and overall survival rates exceeding 90 and …

Opinion statement Despite the use of intensive chemotherapy and hematopoietic stem cell
transplantation, approximately one-third of children with acute myeloid leukemia (AML) still …

Although acute myelogenous leukemia (AML) accounts for< 20% of leukemia in children, it
is responsible for over half of all pediatric leukemia deaths. Improvement in event-free …

Prognosis of childhood acute myeloid leukemia (AML) has improved significantly over the
past decades, from nearly no child surviving to a present probability of cure of approximately …

In recent decades, survival rates for childhood acute myeloid leukemia have remarkably
improved, owing to chemotherapy intensification, allogeneic hematopoietic stem cell …

Pediatric acute myeloid leukemia (AML) is currently associated with survival rates as high as
70%. However, many events still occur, side effects are significant, and late effects occur and …

Pediatric acute myeloid leukemia (AML) represents 15%–20% of all pediatric acute
leukemias. Survival rates have increased over the past few decades to~ 70%, due to …

Further incorporation of genomic and molecular data in pediatric AML will allow for
additional refinements in risk stratification to enable the tailoring of treatment intensity. These …

Abstract Purpose of Review Acute myeloid leukemia (AML) in children remains a
challenging disease to cure with suboptimal outcomes particularly when compared to the …

Introduction: Although the prognosis of pediatric acute myeloid leukemia (pAML) has
improved, with current survival rates up to 75%, relapse rates remain high. Areas covered …